Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 1 (12%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, JAY M | 1 | 64.7% | +38.7% |
| COFFA, SERGIO | 1 | 61.1% | +33.2% |
| PARK, EVELYN GRACE | 1 | 53.5% | +46.0% |
| XIAO, YAN | 1 | 67.8% | +51.6% |
| MELCHIOR, JAMES RYLAND | 1 | 62.7% | +37.7% |
| MARMOR II, CHARLES ALAN | 1 | 12.0% | +24.8% |
| CLOW, LORI A | 1 | 64.0% | +28.6% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17543169 | Method of Determining Disease Causality of Genome Mutations | CLOW, LORI A | 77d |
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | — |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | — |
| 18003256 | MAGNETICALLY ACTUATED CAPSULE | MARMOR II, CHARLES ALAN | — |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17543169 | Method of Determining Disease Causality of Genome Mutations | CLOW, LORI A | 77d |
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | — |
| 18703101 | RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT | COFFA, SERGIO | — |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | — |
| 18263217 | MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS | XIAO, YAN | — |
| 18253483 | POLYPEPTIDES TARGETING DR4 AND/OR DR5 AND RELATED COMPOSITIONS AND METHODS | MELCHIOR, JAMES RYLAND | — |
| 18003256 | MAGNETICALLY ACTUATED CAPSULE | MARMOR II, CHARLES ALAN | — |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 3681 | 1 |
| 1642 | 1 |
| 1658 | 1 |
| 1687 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18800528 | SYSTEM AND METHOD FOR CANCER-CELL SPECIFIC TRANSCRIPTION IDENTIFICATION | PATEL, JAY M | 3681 | §101DP | Non-Final OA | — | Pending | Aug 12, 2024 |
| 18703101 | RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT | COFFA, SERGIO | — | §112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18371847 | APPARATUS FOR AUTOMATED PAIN TESTING IN RODENTS | PARK, EVELYN GRACE | 3791 | §102§103 | Final Rejection | — | Pending | Sep 22, 2023 |
| 18263217 | MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS | XIAO, YAN | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18253483 | POLYPEPTIDES TARGETING DR4 AND/OR DR5 AND RELATED COMPOSITIONS AND METHODS | MELCHIOR, JAMES RYLAND | 1658 | §102§103DP | Non-Final OA | — | Pending | May 18, 2023 |
| 18003256 | MAGNETICALLY ACTUATED CAPSULE | MARMOR II, CHARLES ALAN | 3791 | §103 | Final Rejection | — | Pending | Dec 23, 2022 |
| 17543169 | Method of Determining Disease Causality of Genome Mutations | CLOW, LORI A | 1687 | §103§112 | Final Rejection | 77d | Pending | Dec 06, 2021 |
| 17598272 | COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS | MEYERING, SHABANA SHABBEER | 1635 | §102§103 | Non-Final OA | — | Pending | Sep 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial